IPO of Emcure Pharma

Pune-based Emcure Pharmaceuticals Ltd. is expected to make a market debut with as much as 30% gains on Wednesday, July 10, analysts said. Robust subscription demand for IPO, healthy business prospects are some of key reasons behind the expected decent listing. The grey market premium (GMP) of Emcure Pharmaceuticals has jumped sharplyContinue Reading

Bansal Wire  IPO fully subscribed on Day 1: Witnessing strong buying interest from retail as well as non-institutional investors, the ₹745 crore initial public offering (IPO) of Bansal Wire Industries was fully subscribed within the first four hours on the first day of subscription on Wednesday.  The issue opened for subscription on Wednesday,Continue Reading